Evidence map›Paper›PMID 36650155›Full record

ArticleNature communications2023

High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform.

Cheng-Yong Tham, LaiFong Poon, TingDong Yan, Javier Yu Peng Koh, Muhammad Khairul Ramlee, Vania Swee Imm Teoh, Suihan Zhang, Yi Cai, Zebin Hong, Gina S Lee and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Techniques for assessing telomere length: A methodological review.Computational and structural biotechnology journal · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 4 countries.

Cheng-Yong Tham *Cancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.ORCID 0000-0002-7594-3025
LaiFong Poon *Cancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.ORCID 0000-0002-5123-9033
TingDong YanCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Javier Yu Peng KohCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Muhammad Khairul RamleeCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Vania Swee Imm TeohCancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.ORCID 0000-0003-4594-3865
Suihan ZhangDepartment of Microbiology and Molecular Genetics, University of California, Davis, CA, 95616, USA.ORCID 0000-0002-6602-027X
Yi CaiCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Zebin HongInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
Gina S LeeNational Heart Centre Singapore, Duke-NUS Medical School, 5 Hospital Drive, Singapore, 169609, Singapore.
Jin LiuCentre for Quantitative Medicine, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.ORCID 0000-0002-5707-2078
Hai Wei SongInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, (A*STAR), 61 Biopolis Drive, Singapore, 138673, Singapore.
William Ying Khee HwangCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.
Bin Tean TehCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore.ORCID 0000-0003-1514-1124
Patrick TanCancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore.
Lifeng XuDepartment of Microbiology and Molecular Genetics, University of California, Davis, CA, 95616, USA.ORCID 0000-0002-7887-5451
Angela S KohNational Heart Centre Singapore, Duke-NUS Medical School, 5 Hospital Drive, Singapore, 169609, Singapore.ORCID 0000-0001-5629-9732
Motomi OsatoCancer Science Institute of Singapore, National University of Singapore, 14 Medical Drive, Singapore, 117599, Singapore. motomi.osato@gmail.com.ORCID 0000-0003-3982-9054
Shang LiCancer and Stem Cell Biology Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. shang.li@duke-nus.edu.sg.ORCID 0000-0002-6226-3362
Duke-NUS Medical School · SGAgency for Science, Technology and Research · SGNational University of Singapore · SGUniversity of California, Davis · USChinese University of Hong Kong, Shenzhen · CNGuangdong Pharmaceutical University · CNNational University Cancer Institute, Singapore · SGShanghai University · CNSingapore General Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeres are specialized nucleoprotein structures at the ends of linear chromosomes. The progressive shortening of steady-state telomere length in normal human somatic cells is a promising biomarker for age-associated diseases. However, there remain substantial challenges in quantifying telomere length due to the lack of high-throughput method with nucleotide resolution for individual telomere. Here, we describe a workflow to capture telomeres using newly designed telobaits in human culture cell lines as well as clinical patient samples and measure their length accurately at nucleotide resolution using single-molecule real-time (SMRT) sequencing. Our results also reveal the extreme heterogeneity of telomeric variant sequences (TVSs) that are dispersed throughout the telomere repeat region. The presence of TVSs disrupts the continuity of the canonical (5'-TTAGGG-3')n telomere repeats, which affects the binding of shelterin complexes at the chromosomal ends and telomere protection. These findings may have profound implications in human aging and diseases.

Indexed as

Shelterin ComplexTelomereAgingHumansShelterin Complex

Identifiers

PMID36650155
PMCPMC9845338
OpenAlexW4317034826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.